Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Edwards

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Cancer|June 1, 1987
Intrahepatic infusional therapy for metastatic ovarian carcinomaJ M Malone, D M Gershenson, C H Carrasco, et al.
Gynecologic Oncology|November 1, 1993
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell linesD G Kieback, I B Runnebaum, V J Moebus, et al.
Anti-Cancer Drugs|March 10, 1998
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitorC F Verschraegen, E A Natelson, B C Giovanella, et al.
Cancer|May 1, 1986
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatinD M Gershenson, J J Kavanagh, L J Copeland, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaR S Freedman, J A Gibbons, M Giedlin, et al.
Cancer Research|October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroG Ferrandina, B Melichar, A Loercher, et al.
Sleep|June 1, 1989
Sleep-disordered breathing in healthy aged persons: one-year follow-up of daytime sequelaeD T Berry, B A Phillips, Y R Cook, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
American Journal of Clinical Oncology|February 22, 2000
Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference]S Verstovsek, C F Verschraegen, C L Edwards, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in uteroR A Hajek, D W King, M A Hernández-Valero, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Cancer|June 1, 1987
Intrahepatic infusional therapy for metastatic ovarian carcinomaJ M Malone, D M Gershenson, C H Carrasco, et al.
Gynecologic Oncology|November 1, 1993
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell linesD G Kieback, I B Runnebaum, V J Moebus, et al.
Anti-Cancer Drugs|March 10, 1998
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitorC F Verschraegen, E A Natelson, B C Giovanella, et al.
Cancer|May 1, 1986
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatinD M Gershenson, J J Kavanagh, L J Copeland, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaR S Freedman, J A Gibbons, M Giedlin, et al.
Cancer Research|October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroG Ferrandina, B Melichar, A Loercher, et al.
Sleep|June 1, 1989
Sleep-disordered breathing in healthy aged persons: one-year follow-up of daytime sequelaeD T Berry, B A Phillips, Y R Cook, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
American Journal of Clinical Oncology|February 22, 2000
Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference]S Verstovsek, C F Verschraegen, C L Edwards, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in uteroR A Hajek, D W King, M A Hernández-Valero, et al.
Pageof 16